Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Jennelle Francis"'
Publikováno v:
Cancer Gene Therapy. 18:734-743
Pancreatic adenocarcinoma has a poor prognosis and frequently develops resistance to standard chemotherapeutics. Oncolytic adenoviruses represent a promising approach to overcome treatment resistance. The replication-selective dl922-947 adenovirus, d
Autor:
Yaohe Wang, Liufu Deng, Istvan Fodor, Ziming Dong, Fengyu Cao, Nicholas R. Lemoine, Ghassan Alusi, Shengdian Wang, Shaolong Yang, James R. Tysome, Pengju Wang, Dongling Gao, Jinxia Yu, Arnaud Briat, Tatyana Timiryasova, Jennelle Francis
Publikováno v:
Gene therapy
Gene Therapy
Gene Therapy, 2009, 16 (10), pp.1223-1233. ⟨10.1038/gt.2009.74⟩
Gene Therapy
Gene Therapy, 2009, 16 (10), pp.1223-1233. ⟨10.1038/gt.2009.74⟩
Summary Survival following pancreatic cancer remains poor despite incremental advances in surgical and adjuvant therapy, and new strategies for treatment are needed. Oncolytic virotherapy is an attractive approach for cancer treatment. In this study,
Autor:
Weidong Zang, Yaohe Wang, Nicholas R. Lemoine, Xingbo Zhao, Hongyan Yang, Dongling Gao, Jinxia Yu, Ziming Dong, Vipul Bhakta, James R. Tysome, Kang-dong Liu, Yunhan Zhang, C.P. Chikkanna-Gowda, Rathi Gangeswaran, Claude Chelala, Ming Yuan, Guozhong Jiang, Pengju Wang, Fengyu Cao, Jennelle Francis
Publikováno v:
Journal of Clinical Investigation. 119:1604-1615
The changes in cancer cell surface molecules and intracellular signaling pathways during tumorigenesis make delivery of adenovirus-based cancer therapies inefficient. Here we have identified carcinoembryonic antigen- related cell adhesion molecule 6
Autor:
Gunnel Halldén, Nicholas R. Lemoine, Yaohe Wang, Brooks G, David H. Kirn, Ta-Chiang Liu, Jennelle Francis
Publikováno v:
Gene Therapy. 12:1333-1346
Replication-selective oncolytic adenoviruses hold promise, but novel mechanisms must be identified to maximize intratumoral virus persistence, spread and therapeutic transgene-carrying capacity while maintaining safety. One of the main approaches to
Autor:
Nicholas R. Lemoine, Shao-An Xue, Yaohe Wang, Jennelle Francis, Ming Yuan, Gunnel Halldén, Beverly E. Griffin
Publikováno v:
Cancer Research. 65:1523-1531
Given the growing number of tumor types recognizably associated with EBV infection, it is critically important that therapeutic strategies are developed to treat such tumors. Replication-selective oncolytic adenoviruses represent a promising new plat
Autor:
Ta-Chiang Liu, Arthi Anand, Yaohe Wang, David H. Kirn, Nicholas R. Lemoine, Gabriel Brooks, Richard Hill, Gunnel Halldén, Jennelle Francis
Publikováno v:
Nature Biotechnology. 21:1328-1335
Oncolytic replication-selective adenoviruses constitute a rapidly growing therapeutic platform for cancer. However, the role of the host immune response and the E3 immunoregulatory genes of the human adenovirus were unknown until now. We identified f
Autor:
Gunnel Halldén, Ta-Chiang Liu, Jennelle Francis, Arthi Anand, Yaohe Wang, Lynda Hawkins, Richard Hill, David H. Kirn, Nicholas R. Lemoine
Publikováno v:
Molecular Therapy. 8(3):412-424
Oncolytic replication-selective adenoviruses constitute a rapidly expanding experimental approach to the treatment of cancer. However, due to the lack of an immunocompetent and replication-competent efficacy model, the role of the host immune respons
Autor:
Yaohe Wang, Stephen Thorne, Joseph Hannock, Jennelle Francis, Tina Au, Tony Reid, Nick Lemoine, David Kirn, Gunnel Halldén
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 11(1)
Purpose: Replication-selective oncolytic adenoviruses hold promise for cancer treatment, but the predictive use of cell lines, dissociated tumor tissue, and animal models for efficacy against primary cancers are unclear. To further evaluate cytotoxic
Autor:
Gunnel Halldén, Ghassan Alusi, Yaohe Wang, U. Bapat, Nicholas R. Lemoine, Jennelle Francis, E. Chisholm
Publikováno v:
Clinical Otolaryngology. 31:582-583
Objectives. To evaluate the oncolytic potential of a replication-selective mutant adenovirus (VAI-deleted adenovirus) in an established EBV-positive cancer cell line and to develop a new regime to enhance the potency of the virus by combination with
Autor:
Nicholas R. Lemoine, David H. Kirn, Gunnel Halldén, Jennelle Francis, Richard Hill, Yaohe Wang, Catherine Simpson
Publikováno v:
Molecular Therapy. 9:S374-S375
We recently developed a number of immunocompetent murine tumour models that enabled the evaluation of adenoviruses with classical E3 deletions, dl309 (E3B deleted (RIDa/RIDb complex and 14.7kD)) and dl704 (E3 gp19K deleted). The E3B genes protect inf